{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:40:27Z","timestamp":1756377627428,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,9,16]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Crohn\u2019s disease is frequently associated with hypocalcaemia following poor calcium intake and decreased intestinal calcium absorption due to malabsorption-related vitamin D deficiency. Severe hypercalcaemia found in Crohn\u2019s disease is an unusual clinical entity. We chronicle here the case of a patient who developed hypercalcaemia with elevated 1,25-dihydroxyvitamin D during Crohn\u2019s disease exacerbation. Furthermore, we conducted a systematic literature search of MEDLINE, Cochrane, Embase, and Scopus databases regarding 1,25-dihydroxyvitamin D-associated hypercalcaemia in Crohn\u2019s disease. A comprehensive review of the search results yielded a total of five case reports only. The data on patient demographics, clinical features, serum calcium levels, Crohn\u2019s disease activity site, treatment strategy, hypercalcaemia resolution time and outcomes were collected and analysed. This paper illustrates that Crohn\u2019s disease should be added to the list of granulomatous disorders responsible for 1,25-dihydroxyvitamin D-mediated hypercalcaemia. Physicians should maintain a high index of clinical suspicion for this potential complication for prompt management.<\/jats:p>","DOI":"10.1136\/bcr-2019-230099","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T13:42:42Z","timestamp":1569505362000},"page":"e230099","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Hypercalcaemia due to isolated elevation of 1,25-dihydroxyvitamin D in patients with Crohn\u2019s disease"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-7319","authenticated-orcid":false,"given":"Faisal","family":"Inayat","sequence":"first","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Saleem","sequence":"additional","affiliation":[{"name":"Mercy Saint Vincent Medical Center, Toledo, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Mohyudin","sequence":"additional","affiliation":[{"name":"Sheikh Zayed Medical College, Rahim Yar Khan, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubair","family":"Khan","sequence":"additional","affiliation":[{"name":"University of Toledo Medical Center, Toledo, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"2025082803040405000_12.9.e230099.1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2265.1994.tb02569.x","article-title":"Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations","volume":"41","author":"Walls","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2025082803040405000_12.9.e230099.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704243361706"},{"key":"2025082803040405000_12.9.e230099.3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ndt\/8.6.560","article-title":"Ectopic production of 1,25-dihydroxyvitamin D3 in tuberculosis","volume":"8","author":"Pouchot","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"2025082803040405000_12.9.e230099.4","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2000.0767"},{"key":"2025082803040405000_12.9.e230099.5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-8529(18)30365-7","article-title":"Vitamin D metabolite-mediated hypercalcemia","volume":"18","author":"Adams","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025082803040405000_12.9.e230099.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-9-199411010-00001"},{"key":"2025082803040405000_12.9.e230099.7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0016-5085(82)80135-2","article-title":"Vitamin D deficiency and bone disease in patients with Crohn\u2019s disease","volume":"83","author":"Driscoll","year":"1982","journal-title":"Gastroenterology"},{"key":"2025082803040405000_12.9.e230099.8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.71"},{"key":"2025082803040405000_12.9.e230099.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70327-0"},{"key":"2025082803040405000_12.9.e230099.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.09.008"},{"key":"2025082803040405000_12.9.e230099.11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4158\/EP.14.1.87","article-title":"Active Crohn disease and hypercalcemia treated with infliximab: case report and literature review","volume":"14","author":"Ioachimescu","year":"2008","journal-title":"Endocr Pract"},{"key":"2025082803040405000_12.9.e230099.12","doi-asserted-by":"crossref","first-page":"bcr0720103138","DOI":"10.1136\/bcr.07.2010.3138","article-title":"Rennies, Crohn\u2019s disease and severe hypercalcaemia","volume":"2010","author":"Zemrak","year":"2010","journal-title":"BMJ Case Rep"},{"key":"2025082803040405000_12.9.e230099.13","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-270"},{"key":"2025082803040405000_12.9.e230099.14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-5-960"},{"key":"2025082803040405000_12.9.e230099.15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-1-72"},{"key":"2025082803040405000_12.9.e230099.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.7.2222"},{"key":"2025082803040405000_12.9.e230099.17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(78)91972-4","article-title":"Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders","volume":"2","author":"Studdy","year":"1978","journal-title":"Lancet"},{"key":"2025082803040405000_12.9.e230099.18","first-page":"447","article-title":"The predictive value of serum angiotensin-converting enzyme activity in the differential diagnosis of hypercalcemia","volume":"58","author":"Lufkin","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"2025082803040405000_12.9.e230099.19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1445-5994.1984.tb03580.x","article-title":"Serum angiotensin converting enzyme in Crohn\u2019s disease, ulcerative colitis and peptic ulceration","volume":"14","author":"D\u2019Onofrio","year":"1984","journal-title":"Aust N Z J Med"},{"key":"2025082803040405000_12.9.e230099.20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"2025082803040405000_12.9.e230099.21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-5347(17)53770-2","article-title":"Marked hyperoxaluria in sarcoidosis during orthophosphate therapy","volume":"127","author":"Kogan","year":"1982","journal-title":"J Urol"},{"key":"2025082803040405000_12.9.e230099.22","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V82.5.1383.1383","article-title":"Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas","volume":"82","author":"Seymour","year":"1993","journal-title":"Blood"},{"key":"2025082803040405000_12.9.e230099.23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1090"},{"key":"2025082803040405000_12.9.e230099.24","doi-asserted-by":"crossref","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"key":"2025082803040405000_12.9.e230099.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609183151203"},{"key":"2025082803040405000_12.9.e230099.26","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90237-3"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:04:14Z","timestamp":1756375454000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,26]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bcr-2019-230099"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230099","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}